Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Protagenic Therapeutics Inc (PTIX)

Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Protagenic Therapeutics Inc 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 USA

www.protagenic.com P: 212-994-8200

Description:

Protagenic Therapeutics, Inc. is a biotechnology company. It focused on the discovery, research and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics, Inc., formerly known as Atrinsic, Inc., is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 8,072
Enterprise Value, $K 7,852
Shares Outstanding, K 4,435
Annual Sales, $ 0 K
Annual Net Income, $ -3,560 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,400 K
EBIT, $ -3,970 K
EBITDA, $ -3,860 K
60-Month Beta 0.28
% of Insider Shareholders 37.00%
% of Institutional Shareholders 7.97%
Float, K 2,794
% Float 63.00%
Short Volume Ratio 0.28

Growth:

1-Year Return 12.12%
3-Year Return -92.72%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 11/14/23
Latest Earnings Date 04/02/24 [--]
Earnings Per Share ttm -0.77
EPS Growth vs. Prev Qtr -14.29%
EPS Growth vs. Prev Year -60.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 03/23/23

PTIX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -68.60%
Return-on-Assets % -55.99%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.81
Book Value/Share 0.96
Interest Coverage -24.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar